Scott Bone

19 Patents

• US123183742025

  Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

  Deciphera Pharmaceuticals, LLC

  0 cites
• US122264062025

  Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

  Deciphera Pharmaceuticals, LLC

  0 cites
• US122139672025

  Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

  Deciphera Pharmaceuticals, LLC

  0 cites
• US122139682025

  Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

  Deciphera Pharmaceuticals, LLC

  0 cites
• US120644222024

  Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

  Deciphera Pharmaceuticals, LLC

  0 cites
• US120233282024

  Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

  Deciphera Pharmaceuticals, LLC

  0 cites
• US119694152024

  (methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

  Deciphera Pharmaceuticals, LLC

  0 cites
• US119185642024

  Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

  Deciphera Pharmaceuticals, LLC

  0 cites
• US119113702024

  Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

  Deciphera Pharmaceuticals, LLC

  0 cites
• US119039332024

  Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

  Deciphera Pharmaceuticals, LLC

  0 cites
• US118965852024

  Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea

  Deciphera Pharmaceuticals, LLC

  0 cites
• US118502402023

  Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

  Deciphera Pharmaceuticals, LLC

  0 cites
• US118502412023

  Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

  Deciphera Pharmaceuticals, LLC

  0 cites
• US118447882023

  Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

  Deciphera Pharmaceuticals, LLC

  0 cites
• US118012372023

  Amorphous Kinase Inhibitor Formulations and Methods of Use Thereof

  Deciphera Pharmaceuticals, LLC

  0 cites
• US117937952023

  Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea

  Deciphera Pharmaceuticals, LLC

  0 cites
• US117013622023

  Compositions and Methods of Use of Cis-4-[2-{[(3s,4r)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9h-purin-9-yl]-1- Methylcyclohexane-1-carboxamide

  Celgene Corporation

  0 cites
• US116125912023

  Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea

  Deciphera Pharmaceuticals, LLC

  0 cites
• US115769032023

  Amorphous Kinase Inhibitor Formulations and Methods of Use Thereof

  Deciphera Pharmaceuticals, LLC

  0 cites